The Examination of Emotion Dysregulation as a Moderator of Depression and HIV-Relevant Outcome Relations Among an HIV+Sample
The Examination of Emotion Dysregulation as a Moderator of Depression and HIV-Relevant Outcome Relations Among an HIV+Sample
复制标题
DOI：
10.1080/16506073.2014.950323
复制
发表时间：
2015-01-02
影响因子：
4.7
通讯作者：
Gonzalez, Adam
中科院分区：
文献类型：
--
作者：
Brandt, Charles P.;Bakhshaie, Jafar;Gonzalez, Adam
本研究探讨是否情绪失调调节抑郁症状和艾滋病毒症状之间的关系，艾滋病毒药物治疗的依从性，由于药物副作用，回避应对，和痛苦的宽容与艾滋病毒/艾滋病（PLHA）的人。参与者包括115例PLHA（16.8%女性; M-年龄=49.70，SD=8.57）。结果表明，有一个显着的相互作用，抑郁症状和情绪失调有关的艾滋病毒症状，艾滋病毒药物治疗的依从性，由于药物副作用，回避应对，和痛苦的容忍度。互动的形式表明，PLHA经历更高的抑郁症状和更高水平的情绪失调报告的艾滋病毒症状的最高水平和最低水平的痛苦容忍度。此外，结果表明，在抑郁症状水平较低的情况下，非常高水平的情绪失调预测了更高的药物不依从率，而在抑郁症状水平较高的情况下，非常高水平的情绪失调预测了最低的药物不依从率。此外，那些经历较低水平的抑郁症状和较高水平的情绪失调的人报告的回避应对率最高。总的来说，目前的结果表明情绪失调和抑郁症状之间的复杂相互作用，涉及艾滋病毒症状，药物不依从性和自我调节过程（例如，回避应对、痛苦容忍度）。
The present study examined whether emotion dysregulation moderated the relations between depressive symptoms and HIV symptoms, HIV medication adherence due to medication side effects, avoidant coping, and distress tolerance among people living with HIV/AIDS (PLHA). Participants included 115 PLHA (16.8% female; M-age=49.70, SD=8.57). Results indicated that there was a significant interaction between depressive symptoms and emotion dysregulation in relation to HIV symptoms, HIV medication adherence due to medication side effects, avoidant coping, and distress tolerance. The form of the interaction indicated that PLHA experiencing higher depressive symptoms and higher levels of emotion dysregulation reported the highest levels of HIV symptoms and lowest levels of distress tolerance. Additionally, results indicated that at lower levels of depressive symptoms, very high levels of emotion dysregulation predicted higher rates of medication nonadherence, whereas at higher levels of depressive symptoms, very high levels of emotion dysregulation predicted the lowest rates of medication nonadherence. Moreover, those experiencing lower levels of depressive symptoms and higher levels of emotion dysregulation reported the greatest rates of avoidant coping. In total, the present results suggest a complex interplay between emotion dysregulation and depressive symptoms with regard to HIV symptoms, medication nonadherence, and self-regulatory processes (e.g., avoidant coping, distress tolerance) among PLHA.